534 related articles for article (PubMed ID: 26805758)
21. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC
Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370
[TBL] [Abstract][Full Text] [Related]
22. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
23. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy.
Williams C; Phillips A; Aggarwal V; Slonim LB; Fajgenbaum DC; Karmali R
Case Rep Oncol; 2021; 14(3):1359-1365. PubMed ID: 34720942
[TBL] [Abstract][Full Text] [Related]
24. International definition of iMCD-TAFRO: future perspectives.
Nishimura Y; Nishimura MF; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036
[TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
26. TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.
Louis C; Vijgen S; Samii K; Chalandon Y; Terriou L; Launay D; Fajgenbaum DC; Seebach JD; Muller YD
Front Med (Lausanne); 2017; 4():149. PubMed ID: 29018798
[TBL] [Abstract][Full Text] [Related]
27. Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease.
Pierson SK; Stonestrom AJ; Shilling D; Ruth J; Nabel CS; Singh A; Ren Y; Stone K; Li H; van Rhee F; Fajgenbaum DC
Am J Hematol; 2018 Jul; 93(7):902-912. PubMed ID: 29675946
[TBL] [Abstract][Full Text] [Related]
28. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
29. TAFRO syndrome: 2 cases and review of the literature.
Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
[TBL] [Abstract][Full Text] [Related]
30. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases.
Kojima M; Nakamura S; Nishikawa M; Itoh H; Miyawaki S; Masawa N
Pathol Res Pract; 2005; 201(4):325-32. PubMed ID: 15991840
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
33. TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.
Shirakashi M; Nishida Y; Nakashima R; Fujimoto M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Morinobu A; Yoshifuji H
Sci Rep; 2024 Feb; 14(1):2889. PubMed ID: 38311632
[TBL] [Abstract][Full Text] [Related]
34. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease.
Nishikori A; Nishimura MF; Nishimura Y; Otsuka F; Maehama K; Ohsawa K; Momose S; Nakamura N; Sato Y
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142213
[TBL] [Abstract][Full Text] [Related]
35. Genetic basis for iMCD-TAFRO.
Yoshimi A; Trippett TM; Zhang N; Chen X; Penson AV; Arcila ME; Pichardo J; Baik J; Sigler A; Harada H; Fajgenbaum DC; Dogan A; Abdel-Wahab O; Xiao W
Oncogene; 2020 Apr; 39(15):3218-3225. PubMed ID: 32051554
[TBL] [Abstract][Full Text] [Related]
36. [Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
Jouvray M; Terriou L; Meignin V; Bouchindhomme B; Jourdain M; Lambert M; Lefevre G; Hachulla E; Hatron PY; Galicier L; Launay D
Rev Med Interne; 2016 Jan; 37(1):53-7. PubMed ID: 26411598
[TBL] [Abstract][Full Text] [Related]
37. Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO.
Phillips AD; Kakkis JJ; Tsao PY; Pierson SK; Fajgenbaum DC
J Cell Mol Med; 2022 Jun; 26(11):3147-3152. PubMed ID: 35488725
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab.
Kakiuchi S; Akiyama H; Harima I; Takagi I; Rikitake J; Kozuki Y; Inaba M; Fujiwara H; Kurose N; Yamada S; Masaki Y
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837418
[TBL] [Abstract][Full Text] [Related]
39. Tacrolimus Treatment for TAFRO Syndrome.
Shirai T; Ichikawa S; Saegusa J
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791031
[TBL] [Abstract][Full Text] [Related]
40. Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography.
Ozawa Y; Yamamoto H; Yasuo M; Takahashi H; Tateishi K; Ushiki A; Kawakami S; Fujinaga Y; Asaka S; Sano K; Takayama H; Imamura H; Hanaoka M
Respir Investig; 2017 Mar; 55(2):176-180. PubMed ID: 28274535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]